There is a growing body of medical research supporting the use of CBD for pain relief among patients suffering from debilitating chronic conditions such as multiple sclerosis and arthritis. In particular, CBD is highly effective in reducing pain due to joint inflammation, muscular pain, and arthritic pain. Additionally, CBD is known to improve motor function, increase muscle strength, and increase overall health through its anti-inflammatory properties. In this brief article, explore the ongoing research-backed benefits of CBD for those suffering from debilitating chronic conditions such as arthritis and multiple sclerosis, while also reporting on its potential anti-aging benefits. Explore more about this article here.
Patients suffering from conditions such as cancer, HIV, multiple sclerosis and cerebral palsy have found great benefit in using CBD as a treatment to alleviate pain and improve the effectiveness of certain medications. In recent years, there has been a wealth of research involving the effect of CBD on opioid receptors. For example, in one study published by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, it was demonstrated that CBD significantly reduced the effectiveness of the commonly used opiate, morphine. The study compared the CBD with the effects of morphine on opioid receptors in mice and showed significant differences in the level of affinity for the two chemicals.
In another study, published in a journal of pharmacology, it was revealed that CBD reduced the inflammatory bowel disease Crohn's Disease significantly in test animals. This study found that CBD can prevent the activation of inflammatory bowel hormones and reduce diarrhea associated with Crohn's. Additionally, the scientists discovered that CBD prevented the excretion of excessive amounts of digestive peptide called gastrin. Gastrin is an integral part of the inflammatory bowel system.
Perhaps most compelling evidence supporting the use of CBD comes from the results of a kidney-transplant-study conducted by the National Institute of Child Health and Human Development (NICEHDH) in collaboration with the National Institute of Arthritis and Musculoskeletal and Skin Diseases. In this study, kidney transplants from people who do not have CBD were compared to those who had undergone CBD. The results were entirely unexpected. Those patients who had undergone CBD had drastically lower levels of the substance in their urine, while those who did not had almost no detectable CBD in their system at all. Researchers had previously tested CBD in animals and showed that it significantly delayed the progression of chronic kidney disease. This latest research indicates that the beneficial effects of CBD can extend to humans as well and that even children can benefit from its use. Take a look at this link: StrainSanity.com for more details about this topic.
There have also been different studies conducted on the potential benefits of CBD that directly focus on the benefits it provides to pain relief in pediatric patients. Two such studies published, examined the ability of CBD to reduce pain and improve motor function in children with cerebral palsy. The third published by the American Pain Foundation found that CBD significantly improved motor function in non-CBD controlled subjects. Another research project sponsored by the National Institute on Drug Abuse (NIDA) looked at the effect of CBD on subjects with posttraumatic stress disorder. This focused on two groups of children: one who were severely depressed and another group who were not.
While the studies mentioned above offer promising evidence that CBD can reduce pain and improve overall health in children suffering from cerebral palsy, chronic pain, or multiple sclerosis (MS), more research is still needed to fully understand the physiological mechanisms through which CBD works. Several areas of the nervous system including the gastrointestinal tract, the brain, the central nervous system, and the immune system are all being studied in order to uncover CBD's pain-relieving and anti-inflammatory potentials. Because of the ongoing need for additional funding in this area, there is an urgent need for clinical investigators to sign up for clinical trials in the area of child neurology and pain management. Clinical trials may provide definitive answers in the next few years about the effectiveness and safety of CBD as a stand-alone anti-inflammatory and anti-psychotic medicine. Explore more about cannabinoid here: https://en.wikipedia.org/wiki/Cannabinoid.
